Clindamycin-induced acute cholestatic hepatitis

World Journal of Gastroenterology

Volumn 13, Issue 40, 2007, Pages 5408-5410

  Aygün, Cem ^a   Kocaman, Orhan ^a   Gürbüz, Yeşim ^a   Şentürk, Ömer ^a   Hülagü, Sadettin ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Clindamycin; Hepatic injury; Hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLINDAMYCIN; GAMMA GLUTAMYLTRANSFERASE; PROTHROMBIN;

ADULT; ANOREXIA; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; CONVALESCENCE; DISEASE SEVERITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; MEDICAL ASSESSMENT; NAUSEA; PROBABILITY; PROTHROMBIN TIME; PRURITUS; RATING SCALE; TOOTH INFECTION; TOXIC HEPATITIS; TREATMENT DURATION; VOMITING;

EID: 35248839560     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i40.5408     Document Type: Article

References (9)

1. Mazur D, Schug BS, Evers G, Larsimont V, Fieger-Buschges H, Gimbel W, Keilbach-Bermann A, Blume HH. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation. Int J Clin Pharmacol Ther 1999; 37: 386-392
2. DeHaan RM, Metzler CM, Schellenberg D, VandenBosch WD, Masson EL. Pharmacokinetic studies of clindamycin hydrochloride in humans. Int J Clin Pharmacol 1972; 6: 105-119
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
4. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-485
5. Farrel GC. Liver disease caused by drugs, anesthetics and toxins. In: Mark Feldman, Lawrence S Friedman, Marvin H, editors. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders, 2002: 1403-1437
6. Chitturi S, Farrell GC. Drug-Induced Liver Disease. Curr Treat Options Gastroenterol 2000; 3: 457-462
7. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683-693
8. Depta JP, Pichler WJ. Cross-reactivity with drugs at the T cell level. Curr Opin Allergy Clin Immunol 2003; 3: 261-267
9. Altraif I, Lilly L, Wanless IR, Heathcote J. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprimsulfamethoxazole. Am J Gastroenterol 1994; 89: 1230-1234